Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment

Overview of attention for article published in Frontiers in oncology, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 71 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 60 publications that cite this research output.

60

The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.

CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.

Article in Journal of Clinical Oncology (June 2024)

Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation.

Article in Journal of Oncology Pharmacy Practice (April 2024)

From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC)

Article in Diagnostics (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.